Table 3.
Control† | Intervention† | Risk difference (95% CI) | Odds ratio (95% CI) | P value* | |
Infants who received OPV 0 within 2 weeks of birth | 341 (64.6%) | 361 (66.0%) | 1.7% (-3.6% to 8.4%) | 1.08 (0.77 to 1.51) | 0.663 |
Infants who received measles I by 12 months of age | 328 (74.0%) | 339 (87.6%) | 13.2% (9.1% to 18.4%) | 2.71 (1.45 to 5.04) | 0.002 |
Fully immunised infants (≤12 months) per WHO standards | 324 (73.6%) | 352 (88.9%) | 15.6% (11.5% to 20.9%) | 3.52 (1.74 to 7.12) | <0.001 |
Fully-immunised infants (≤12 months) per Republic of Kenya MOH standards | 320 (73.1%) | 348 (87.7%) | 15.1% (10.4% to 20.3%) | 3.16 (1.61 to 6.21) | <0.001 |
*P value is for OR from mixed effect logistic regression.
†Denominators are based on number of women reporting the particular outcome. See online supplemental table S1 for details.
OPV, oral polio vaccine.